サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750771

局所麻酔薬の市場規模、シェア、動向分析レポート：薬剤別、用途別、地域別、セグメント予測、2025年～2030年

Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
局所麻酔薬の市場規模、シェア、動向分析レポート：薬剤別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月22日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

局所麻酔薬市場の成長と動向：

Grand View Researchの最新レポートによると、世界の局所麻酔薬の市場規模は2030年までに51億3,000万米ドルに達すると予測されています。

同市場は2025年から2030年にかけてCAGR3.70％で成長すると予測されています。美容手術、歯科処置、形成手術など、世界中で外科処置の件数が増加していることが、局所麻酔薬の成長を促進しています。

術後の疼痛緩和を必要とする外科手術の数はかなり増加しており、この動向は予測期間を通じて続くと予想されます。おおよそ、外科手術全体の65.0％が術後疼痛管理を必要としています。これが局所麻酔薬の需要を押し上げると思われます。

レボブピバカイン、アルチカイン、ロピバカインなどの効果的な新薬の導入も、全世界の局所麻酔薬市場の成長を後押ししています。新興諸国におけるヘルスケア支出の増加は、インド、中国、ブラジルなどの国々で実施される手術件数の増加をもたらすと予想されます。これは、同地域の市場成長に寄与すると考えられます。

局所麻酔薬市場のレポートハイライト

  • 用途別では、市場は注射薬と表面麻酔薬に二分されます。さまざまな外科手術で幅広く使用されることから、予測期間中は注射剤分野が局所麻酔薬市場を独占するとみられます。ドラッグデリバリーシステムの進歩が、予測期間中、表面麻酔薬市場を牽引すると予想されます。
  • 北米は、同地域で行われる外科手術の数が多いことから、局所麻酔薬市場で最大のシェアを占めています。
  • アジア太平洋の局所麻酔薬産業は、急速な都市化とヘルスケアインフラの改善により、予測期間中に最も速いCAGRを記録すると予測されています。
  • 薬剤別では、リドカインが2024年に28.88％のシェアを占め、市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 局所麻酔薬市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析-ポーターのファイブフォース分析
    • PESTLE分析
    • パイプライン分析
    • 特許満了分析
    • 価格分析

第4章 局所麻酔薬市場：薬剤ビジネス分析

  • 薬剤市場シェア、2024年・2030年
  • 薬剤セグメントダッシュボード
  • 市場規模、予測、動向分析（薬剤別、2018年～2030年）
  • ブピバカイン
  • ロピバカイン
  • リドカイン
  • クロロプロカイン
  • プリロカイン
  • ベンゾカイン
  • その他

第5章 局所麻酔薬市場：用途ビジネス分析

  • アプリケーション市場シェア、2024年・2030年
  • アプリケーションセグメントダッシュボード
  • 市場規模、予測、動向分析（用途別、2018年～2030年）
  • 注射剤
  • 表面麻酔薬

第6章 局所麻酔薬市場：地域推定・動向分析

  • 地域別市場シェア分析、2024年・2030年
  • 地域市場ダッシュボード
  • 市場規模と予測動向分析、2018年～2030年：
  • 北米
    • 国別、2018年～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加企業概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/一覧
    • Johnson &Johnson Services, Inc.
    • Pfizer Inc
    • AstraZeneca
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc
    • Sanofi
    • Merck &Co., Inc.
    • Aspen Holdings
    • Viatris Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global local anesthesia drugs market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 5 Global local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 8 North America local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 10 U.S. local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 12 Canada local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 14 Mexico local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 17 Europe local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 19 UK local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 20 Germany local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 21 Germany local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 22 France local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 23 France local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 24 Italy local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 25 Italy local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 26 Spain local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 27 Spain local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 28 Norway local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 29 Norway local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 30 Denmark local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 31 Denmark local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 32 Sweden local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 33 Sweden local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 37 Japan local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 38 Japan local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 39 China local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 40 China local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 41 India local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 42 India local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 43 Australia local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 44 Australia local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 45 South Korea local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 46 South Korea local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 47 Thailand local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 48 Thailand local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 49 Latin America local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 51 Latin America local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 52 Brazil local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 53 Brazil local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 54 Argentina local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 55 Argentina local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa local anesthesia drugs market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Africa local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 60 South Africa local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 63 UAE local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 64 UAE local anesthesia drugs market, by application, 2018 - 2030 (USD Million)
  • Table 65 Kuwait local anesthesia drugs market, by drug, 2018 - 2030 (USD Million)
  • Table 66 Kuwait local anesthesia drugs market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Local anesthesia drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape
  • Fig. 11 Local anesthesia drugs market dynamics
  • Fig. 12 Local anesthesia drugs market: Porter's five forces analysis
  • Fig. 13 Local anesthesia drugs market: PESTLE analysis
  • Fig. 14 Drug market, 2018 - 2030 (USD Million)
  • Fig. 15 Bupivacaine market, 2018 - 2030 (USD Million)
  • Fig. 16 Ropivacaine market, 2018 - 2030 (USD Million)
  • Fig. 17 Lidocaine market, 2018 - 2030 (USD Million)
  • Fig. 18 Chloroprocaine market, 2018 - 2030 (USD Million)
  • Fig. 19 Prilocaine market, 2018 - 2030 (USD Million)
  • Fig. 20 Benzocaine market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Application market, 2018 - 2030 (USD Million)
  • Fig. 23 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 24 Surface Anesthetic market, 2018 - 2030 (USD Million)
  • Fig. 25 Local anesthesia drugs market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway country dynamics
  • Fig. 46 Norway local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden country dynamics
  • Fig. 48 Sweden local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan country dynamics
  • Fig. 53 Japan local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 54 China country dynamics
  • Fig. 55 China local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 India country dynamics
  • Fig. 57 India local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia country dynamics
  • Fig. 59 Australia local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil country dynamics
  • Fig. 66 Brazil local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina country dynamics
  • Fig. 68 Argentina local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa country dynamics
  • Fig. 71 South Africa local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia country dynamics
  • Fig. 73 Saudi Arabia local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE country dynamics
  • Fig. 75 UAE local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait country dynamics
  • Fig. 77 Kuwait local anesthesia drugs market, 2018 - 2030 (USD Million)
  • Fig. 78 Company categorization
  • Fig. 79 Company market position analysis, 2024
  • Fig. 80 Strategic framework
目次
Product Code: GVR-2-68038-086-6

Local Anesthesia Drugs Market Growth & Trends:

The global local anesthesia drugs market size is anticipated to reach USD 5.13 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 3.70% from 2025 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

Local Anesthesia Drugs Market Report Highlights:

  • By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period.
  • North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region.
  • Asia Pacific local anesthesia drugs industry is anticipated to witness the fastest CAGR over the forecast period due to rapid urbanization and improvements in healthcare infrastructure.
  • By Drug segment, Lidocaine dominated the market with a 28.88% share in 2024, driven by its extensive use in injectable and topical anesthetic formulations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Local Anesthesia Drugs Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
      • 3.3.3.1. Phase 1
      • 3.3.3.2. Phase 2
      • 3.3.3.3. Phase 3
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Local Anesthesia Drugs Market: Drug Business Analysis

  • 4.1. Drug Market Share, 2024 & 2030
  • 4.2. Drug Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
  • 4.4. Bupivacaine
    • 4.4.1. Bupivacaine Market, 2018 - 2030 (USD Million)
  • 4.5. Ropivacaine
    • 4.5.1. Ropivacaine Market, 2018 - 2030 (USD Million)
  • 4.6. Lidocaine
    • 4.6.1. Lidocaine Market, 2018 - 2030 (USD Million)
  • 4.7. Chloroprocaine
    • 4.7.1. Chloroprocaine Market, 2018 - 2030 (USD Million)
  • 4.8. Prilocaine
    • 4.8.1. Prilocaine Market, 2018 - 2030 (USD Million)
  • 4.9. Benzocaine
    • 4.9.1. Benzocaine Market, 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Local Anesthesia Drugs Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Injectable
    • 5.4.1. Injectable Market, 2018 - 2030 (USD Million)
  • 5.5. Surface Anesthetic
    • 5.5.1. Surface Anesthetic Market, 2018 - 2030 (USD Million)

Chapter 6. Local Anesthesia Drugs Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Local Anesthesia Drugs Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Local Anesthesia Drugs Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Local Anesthesia Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Johnson & Johnson Services, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Pfizer Inc
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. AstraZeneca
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Novartis AG
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Teva Pharmaceutical Industries Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. GSK plc
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sanofi
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Merck & Co., Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Aspen Holdings
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Viatris Inc.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives